All Posts By

Alfred O'Neill

H2H Marketing is here: Is Biopharma ready? Probably not.

By | Artificial Intelligence, Communities, hospitals, patient-centricity, providers, Strategy, Uncategorized, Web/Tech | No Comments

Well, technology and marketing have caught up with a post I did nearly 2 years ago: the emergence of Human-to-Human marketing. Let’s do an update. The rapid evolution of marketing automation, BI tools, the ability to build a patient or customer profile based on far more than one-dimensional Rx consumption or prescribing habits, the era of Human-to-Human marketing is on our doorstep. Are we as Biopharma marketers ready and able? Probably not. But understanding what has evolved is also to understand how best to take advantage of it. To start to understand truly “human marketing” you need to see that equal value if the analytical tools, but also empathy and compassion. Cleveland Clinic sets the bar high but we should…

Read More

11 CEO’s weigh in: Is there one main thing you could do to fix the healthcare system?

By | Biopharma, Communities, Current Affairs, hospitals, patient-centricity, providers | No Comments

Is there one main thing you could do to fix the healthcare system? Becker’s Hospital Review asked 11 healthcare system CEO’s what was the the one thing they each would do first to fix the system we have. What is interesting is not just what they say, but the implication that no matter what aspect of healthcare you work in, the challenges seem enormous and unresolved. It is like a wound that will not heal. For those of us working on the manufacturer side, these pithy quotes are eye-opening and can be taken as dire. But flip it on its head: these also expose opportunities for the Biopharma industry, which is in a tumult itself. Can these challenges be an…

Read More

What is Value-based medicine? Is this patient or profit-centric?

By | Biopharma, Books, Communities, patient-centricity, Strategy, Thinking Out Loud, value-based medicine | No Comments

Value-Based medicine. Everyone is talking about it; biopharma is questioning what the managed market model will be when they launch new drugs, lots of hand-wringing and a fair dose of confusion (that included me, too!). So let’s use a recent Deloitte report and some CMS content to define it. What I ask is: do any of you readers see this impacting your brands today? Are people putting their heads in the sand? Are they accepting the inevitable and trying to shape it? Here’s an infographic from a Xerox company healthcare survey: After taking in that content and facts from the survey, it seems that uncertainty as to whom Value-based serves is greater than the end goal of better quality care…

Read More

30,000 new patients? Free consults? Telehealth/Telemedicine takes off. (But can doctors compete?)

By | Artificial Intelligence | No Comments

(A 3-minute read but great content to explore to get the deeper story! I am going to bookend this post.) Here’s a novel idea: maybe Biopharma can expand their business model to include tele-health services and develop this new revenue stream and offer it to large health systems? These past few weeks seemed like “Tele-health Month” in my email and in the content I read weekly. But as usual amidst all the noise, market and human realities need to be considered. Before we get to the take-off of tele-health, let’s look at the current leader of the treatment model — the doctor. Tele-health vendors are filling in some vital cracks in the health system. Doctors in large systems or in…

Read More

The A.I. Challenge: What happens when robots replace truck drivers? A fascinating view of one economic theory.

By | Artificial Intelligence, Biopharma, Current Affairs, Strategy, Web/Tech | No Comments

AI is seeping into our conscious but not as quickly as it is seeping into the technology we already use or about to purchase — like Amazon Echo or Financial Service Bots, to name two. What happens when robots replace drivers? Not just like the Uber Pittsburgh pilot, or those in Silicon Valley, I am speaking of the real truck drivers — and the Pew interactive graphic is a bit stunning to view — never did I imagine in so many states being a truck driver in the dominant job. This email from the Octalysis a Weekly email, which usually has a singular focus on gamification but this week took a social engineering note that blew my mind. Here is…

Read More

An Enduring Content Strategy and Mission Statement about Death and Humankind

By | Biopharma, Uncategorized | No Comments

“…Any man’s death diminishes me, because I am involved in mankind…” Working in healthcare is more than selling or marketing or manufacturing, it is about life, death, health and hope. If you work in healthcare, you need to know of this enduring content and its resonant power across the centuries. Have any of you read John Donne’s poem “No Man Is An Island”? Or “Death Be Not Proud”? Whether you have or not, what is amazing is that although his poems are over 350 years old, most of us, across the generations have heard or used a phrase or two from them.  In many ways, many of his words ring true to why we do what we do when you…

Read More

In health is the notion of “Trust” as important as a good User Experience? A new study offers the stunning truth.

By | Biopharma | No Comments

Summary: one new study by Makovsky/Kelton delves into the latest trends of online behavior and the issue of trust among key audiences and healthcare. The results seem to indicate that a good User Experience is almost as important as the source, if not more! Read on for the story and stats, and a few helpful conclusions. Are we really so superficial? Or have we as consumers finally reached that tipping point of where our Experience with Web site content is truly how we frame our trust of that content? Just check out this chart and see how the “trust” chart line and the “ease-of-use” from the Makovsky “Pulse of Online Search Survey, 2016”. I love human contradictions. We are so simple…

Read More

100,000 doctors in school now will NOT go into practice. Why is this good news?

By | Biopharma | No Comments

Why would 100,000 doctors currently in medical school not go into practice? Why would they turn away from serving patients and following their mission? And why is this potentially good news? There are many reasons, some obvious, some not. I am shocked by the number, but not surprised. And you know what, it makes sense. Let’s look at the debate and review some technologies changing health care delivery — created by doctors! In this post we will review this trend in medicine with Healthtap and Ginger.io. According to several studies, summarized well in a blog by a medical student, Ryan Gamlin, on MedicalEconomics.com, the list is long: Pressures of the post-ACA medical practice. Conflict between doctors on the front-line and hospital managers…

Read More

Does Biopharma “get” the role of caregiver? Do any of us really market to their needs? Ask 65 million people. (Part 1 of 2).

By | Biopharma, Communities, Strategy, Web/Tech | No Comments

Summary: 65 million caregivers. Their role is often undefined, undeserved and undersupported. Are we as marketers, and as human beings, missing out on a key audience and the opportunity to engage with a key Influencer? Caregivers challenges are formidable — there must be ways to help. While this is an ever-growing part of the population, we as brand marketers in healthcare need them on our side — or rather, we need to be at their side! Remember, when your branded treatment needs to be part of the conversation, a caregiver may be your best sales force!  So, best advice: don’t reinvent the wheel. Check out the numerous existing resources (some examples in this post) before developing any strategy; look to…

Read More

Biopharma listened! IMS reports on health apps improving

By | Biopharma | No Comments

IMS is a highly trusted source of news and data for the entire healthcare industry. But often the focus is on Biopharma — and in this one specific instance — a new update on their tracking the evolution of health apps for patients and doctors. They report that as of end of 2015, there were over 165,000 health-related apps in the market. In this report, IMS analyzed over 26,000 of these apps. While improvement has occurred from earlier reports (which had the abysmal stats of 75% of all health apps abandoned after 3 months!) there is still much work to do. But this new report is a mixed bag or encouraging progress and what is still left to do to…

Read More